x

Zymeworks Inc. (Nasdaq:ZYME)

Health Care/Life Sciences • Biotechnology
CIK 1937653
Company

Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Zanidatamab's unique binding properties result in multiple mechanisms of action that may enable it to address unmet need in patient populations with HER2-expressing cancers. The company was founded on September 8, 2003 and is headquartered in Middletown, DE.

Address
108 Patriot Drive
Suite A
Middletown, Delaware 19709
Employees
294
Stock Info
Close
$11.98
Day Range
11.85 - 12.55
52 Week Range
6.02 - 13.14
Average volume
505.65K
Short Interest
3.26M (02/15/24)
% of Float Shorted
4.98%
Market Cap
$883.87M
Revenue
$412.48M
Net Income
$124.34M
2020 Sales Growth
N/A
Rev. per Employee
$1.570M
P/E Ratio
4.28
EPS
$2.80
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman, President & Chief Executive Officer
Kenneth Harry Galbraith
Director
Alessandra Cesano MD, PhD
Director
Nancy E Davidson MD
Director
Scott Benjamin Platshon
Independent Director
Carlos E Campoy MBA
Independent Director
Troy M Cox MBA
Lead Independent Director
Susan Mahony PhD, MBA
Independent Director
Kelvin M Neu MD, PhD
Independent Director
Hollings Chase Renton III, MBA
Independent Director
Derek J Miller MBA
SEC filings
DateFormEvent
3 Sep, 2024 8-K
3 Sep, 2024 3
3 Sep, 2024 4
2 Aug, 2024 424B5
2 Aug, 2024 8-K
1 Aug, 2024 8-K
1 Aug, 2024 10-Q
1 Aug, 2024 8-K
25 Jul, 2024 8-K
11 Jun, 2024 144
10 Jun, 2024 8-K
3 May, 2024 424B5
3 May, 2024 424B5
3 May, 2024 8-K
2 May, 2024 10-Q
2 May, 2024 S-3ASR
2 May, 2024 8-K
4 Apr, 2024 8-K
2 Apr, 2024 4
2 Apr, 2024 3
1 Apr, 2024 8-K CEO Change
28 Mar, 2024 8-K
7 Mar, 2024 S-8
7 Mar, 2024 S-3ASR
7 Mar, 2024 RW
6 Mar, 2024 10-K
6 Mar, 2024 8-K
6 Mar, 2024 S-3
4 Mar, 2024 3
22 Feb, 2024 8-K
22 Feb, 2024 SC 13D
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
9 Feb, 2024 SC 13G/A
9 Feb, 2024 3
9 Feb, 2024 4
8 Feb, 2024 8-K
29 Jan, 2024 SC 13G
8 Jan, 2024 4
8 Jan, 2024 4
8 Jan, 2024 4
8 Jan, 2024 4
5 Jan, 2024 144
5 Jan, 2024 144
5 Jan, 2024 144
5 Jan, 2024 3
5 Jan, 2024 8-K
4 Jan, 2024 8-K
3 Jan, 2024 D
28 Dec, 2023 4
26 Dec, 2023 8-K
11 Dec, 2023 4
8 Dec, 2023 4
8 Dec, 2023 4
8 Dec, 2023 4
8 Dec, 2023 4
8 Dec, 2023 8-K
8 Dec, 2023 4
8 Dec, 2023 4
8 Dec, 2023 4
8 Dec, 2023 4
8 Dec, 2023 3
7 Nov, 2023 10-Q
7 Nov, 2023 8-K
2 Nov, 2023 8-K
26 Oct, 2023 ARS
26 Oct, 2023 DEF 14A
26 Oct, 2023 DEFA14A
16 Oct, 2023 8-K
21 Sep, 2023 8-K
10 Aug, 2023 8-K
10 Aug, 2023 10-Q
30 Jun, 2023 4
30 Jun, 2023 3
29 Jun, 2023 8-K
21 Jun, 2023 4
21 Jun, 2023 SC 13G/A
12 Jun, 2023 8-A12B/A
12 Jun, 2023 8-K
5 Jun, 2023 8-K
18 May, 2023 8-K CEO Change
16 May, 2023 8-K
8 May, 2023 10-Q
8 May, 2023 424B5
8 May, 2023 8-K
8 May, 2023 424B5
28 Apr, 2023 EFFECT
28 Apr, 2023 10-K/A
26 Apr, 2023 8-K
18 Apr, 2023 8-K
10 Apr, 2023 3
10 Apr, 2023 4
10 Apr, 2023 8-K
30 Mar, 2023 4
17 Mar, 2023 8-K
15 Mar, 2023 8-K
14 Mar, 2023 4
7 Mar, 2023 10-K
7 Mar, 2023 POS AM
7 Mar, 2023 POSASR
7 Mar, 2023 S-8
7 Mar, 2023 8-K
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G/A
10 Feb, 2023 SC 13G/A
10 Feb, 2023 SC 13G
2 Feb, 2023 SC 13G/A
23 Jan, 2023 4
19 Jan, 2023 8-K
18 Jan, 2023 4
12 Jan, 2023 4
6 Jan, 2023 4
6 Jan, 2023 4
6 Jan, 2023 4
6 Jan, 2023 4
4 Jan, 2023 8-K
3 Jan, 2023 SC 13G
30 Dec, 2022 8-K
28 Dec, 2022 SC 13D/A
28 Dec, 2022 SC 13D/A
23 Dec, 2022 4/A
23 Dec, 2022 4/A
23 Dec, 2022 4
23 Dec, 2022 4
23 Dec, 2022 4
23 Dec, 2022 4
23 Dec, 2022 4
23 Dec, 2022 4
23 Dec, 2022 4
23 Dec, 2022 4
21 Dec, 2022 8-K
19 Dec, 2022 8-K
19 Dec, 2022 8-K
15 Dec, 2022 CERT
15 Dec, 2022 8-A12B
15 Dec, 2022 25
14 Dec, 2022 4
9 Dec, 2022 8-K
8 Dec, 2022 DEFA14A
5 Dec, 2022 8-K
29 Nov, 2022 8-K
18 Nov, 2022 8-K
14 Nov, 2022 4
9 Nov, 2022 8-K
9 Nov, 2022 424B5
8 Nov, 2022 8-K
8 Nov, 2022 10-Q
1 Nov, 2022 SC 13G/A
1 Nov, 2022 3
28 Oct, 2022 SC 13G
28 Oct, 2022 8-K
21 Oct, 2022 8-K
21 Oct, 2022 424B5
19 Oct, 2022 8-K
18 Oct, 2022 4/A
17 Oct, 2022 SC 13G
17 Oct, 2022 4
17 Oct, 2022 3
17 Oct, 2022 3
13 Oct, 2022 S-8 POS
13 Oct, 2022 S-8 POS
13 Oct, 2022 S-8 POS
13 Oct, 2022 S-8 POS
13 Oct, 2022 POSASR
13 Oct, 2022 8-K12B
13 Oct, 2022 8-K
13 Oct, 2022 424B5
7 Oct, 2022 S-4MEF
2 Sep, 2022 EFFECT
2 Sep, 2022 424B3
30 Aug, 2022 CORRESP
19 Aug, 2022 S-4/A
19 Aug, 2022 CORRESP
8 Aug, 2022 UPLOAD
15 Jul, 2022 425
15 Jul, 2022 S-4
15 Jul, 2022 425
15 Jul, 2022 425
15 Jul, 2022 425
15 Jul, 2022 425
Last update:2024-03-06 12:28:17.067579

Sign Up to Subscribe